CrushSCI.com
54平均天数
54中位天数
54最短天数
54最长天数
1202025发文量

Paper Review Records

全部论文审稿周期

1 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

54 天

An integrated CT/MRI diagnostic system for pancreatic cystic lesions that supports pathological classification and risk stratification

作者
Xiaonan Cui; Houpu Liu; Sunyi Zheng; Hongwei Wang; Jiaxin Liu; Ziyi Gao; Tianye Liu; Jing Liang; Xiaoxu Wang; Xinru Zheng; Jing Wang; Keyi Bian; Xiaomeng Yang; Chunlin Zhang; Tianshuo Jiao; Yufei Yang; Shuxuan Fan; Xiuchao Wang; Song Gao; Chuntao Gao; Yukuan Feng; Hui Li; Guoping Xu; Xiang Zhang; Wen Shen; Haoran Sun; Baocun Sun; Yan Sun; Jianyu Xiao; Yalin Zheng; Michael Ying; Geertruida H. de Bock; Zhaoxiang Ye; Jihui Hao展开收起
作者单位
1. Department of Radiology, National Clinical Research Center for Cancer, Tianjin Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; 2. Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; 3. Pancreas Center, National Clinical Research Center for Cancer, Tianjin Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; 4. Queen Mary School Hainan, Beijing University of Posts and Telecommunications, Lingshui 570203, China; 5. Department of Radiology, First Affiliated Hospital of Hainan Medical University, Haikou 570102, China; 6. Center for Health Statistics and Information, National Health Commission of the PRC, Beijing 100044, China; 7. School of Public Health, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; 8. Department of Medical Imaging, Jinan Third People’s Hospital, Jinan 250101, China; 9. Department of Gastrointestinal Cancer Biology, National Clinical Research Center for Cancer, Tianjin Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; 10. Department of Radiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China; 11. Department of Radiology, Tianjin NanKai Hospital, Tianjin Medical University, Tianjin 300100, China; 12. Department of Radiology, Tianjin First Central Hospital, Tianjin 300192, China; 13. Department of Radiology, Tianjin Medical University General Hospital, Tianjin 300052, China; 14. Department of Pathology, National Clinical Research Center for Cancer, Tianjin Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; 15. Department of Eye and Vision Science, University of Liverpool, United Kingdom, Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool L7 8TX, United Kingdom; 16. Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon 999077, Hong Kong SAR, China; 17. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands展开收起
PDF源文件 DOI 网页

FAQ

Cancer Biology & Medicine审稿要多久?

截至2026-11-19,CrushSCI 只收录了 Cancer Biology & Medicine 的 1 篇完整审稿记录:An integrated CT/MRI diagnostic system for pancreatic cystic lesions that supports pathological classification and risk stratification,2026-07-15 收稿,2026-09-07 录用,审稿 54 天。只有一篇样本,结果仅供参考。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。